These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
274 related articles for article (PubMed ID: 32949495)
1. In Vivo HSC Gene Therapy Using a Bi-modular HDAd5/35++ Vector Cures Sickle Cell Disease in a Mouse Model. Li C; Wang H; Georgakopoulou A; Gil S; Yannaki E; Lieber A Mol Ther; 2021 Feb; 29(2):822-837. PubMed ID: 32949495 [TBL] [Abstract][Full Text] [Related]
2. Targeted Integration and High-Level Transgene Expression in AAVS1 Transgenic Mice after In Vivo HSC Transduction with HDAd5/35++ Vectors. Li C; Mishra AS; Gil S; Wang M; Georgakopoulou A; Papayannopoulou T; Hawkins RD; Lieber A Mol Ther; 2019 Dec; 27(12):2195-2212. PubMed ID: 31494053 [TBL] [Abstract][Full Text] [Related]
3. Reactivation of γ-globin in adult β-YAC mice after ex vivo and in vivo hematopoietic stem cell genome editing. Li C; Psatha N; Sova P; Gil S; Wang H; Kim J; Kulkarni C; Valensisi C; Hawkins RD; Stamatoyannopoulos G; Lieber A Blood; 2018 Jun; 131(26):2915-2928. PubMed ID: 29789357 [TBL] [Abstract][Full Text] [Related]
4. Curative in vivo hematopoietic stem cell gene therapy of murine thalassemia using large regulatory elements. Wang H; Georgakopoulou A; Li C; Liu Z; Gil S; Bashyam A; Yannaki E; Anagnostopoulos A; Pande A; Izsvák Z; Papayannopoulou T; Lieber A JCI Insight; 2020 Aug; 5(16):. PubMed ID: 32814708 [TBL] [Abstract][Full Text] [Related]
5. In vivo hematopoietic stem cell gene therapy ameliorates murine thalassemia intermedia. Wang H; Georgakopoulou A; Psatha N; Li C; Capsali C; Samal HB; Anagnostopoulos A; Ehrhardt A; Izsvák Z; Papayannopoulou T; Yannaki E; Lieber A J Clin Invest; 2019 Feb; 129(2):598-615. PubMed ID: 30422819 [TBL] [Abstract][Full Text] [Related]
6. Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study. Urbinati F; Campo Fernandez B; Masiuk KE; Poletti V; Hollis RP; Koziol C; Kaufman ML; Brown D; Mavilio F; Kohn DB Hum Gene Ther; 2018 Oct; 29(10):1153-1166. PubMed ID: 30198339 [TBL] [Abstract][Full Text] [Related]
7. In vivo base editing by a single i.v. vector injection for treatment of hemoglobinopathies. Li C; Georgakopoulou A; Newby GA; Everette KA; Nizamis E; Paschoudi K; Vlachaki E; Gil S; Anderson AK; Koob T; Huang L; Wang H; Kiem HP; Liu DR; Yannaki E; Lieber A JCI Insight; 2022 Oct; 7(19):. PubMed ID: 36006707 [TBL] [Abstract][Full Text] [Related]
8. In vivo HSPC gene therapy with base editors allows for efficient reactivation of fetal γ-globin in β-YAC mice. Li C; Georgakopoulou A; Mishra A; Gil S; Hawkins RD; Yannaki E; Lieber A Blood Adv; 2021 Feb; 5(4):1122-1135. PubMed ID: 33620431 [TBL] [Abstract][Full Text] [Related]
9. Correction of murine sickle cell disease using gamma-globin lentiviral vectors to mediate high-level expression of fetal hemoglobin. Pestina TI; Hargrove PW; Jay D; Gray JT; Boyd KM; Persons DA Mol Ther; 2009 Feb; 17(2):245-52. PubMed ID: 19050697 [TBL] [Abstract][Full Text] [Related]
10. HDAd5/35 Li C; Psatha N; Gil S; Wang H; Papayannopoulou T; Lieber A Mol Ther Methods Clin Dev; 2018 Jun; 9():390-401. PubMed ID: 30038942 [TBL] [Abstract][Full Text] [Related]
11. Integrating HDAd5/35++ Vectors as a New Platform for HSC Gene Therapy of Hemoglobinopathies. Li C; Psatha N; Wang H; Singh M; Samal HB; Zhang W; Ehrhardt A; Izsvák Z; Papayannopoulou T; Lieber A Mol Ther Methods Clin Dev; 2018 Jun; 9():142-152. PubMed ID: 29766024 [TBL] [Abstract][Full Text] [Related]
12. Hematopoietic Stem Cell Gene-Addition/Editing Therapy in Sickle Cell Disease. Germino-Watnick P; Hinds M; Le A; Chu R; Liu X; Uchida N Cells; 2022 Jun; 11(11):. PubMed ID: 35681538 [TBL] [Abstract][Full Text] [Related]
17. Preclinical evaluation for engraftment of CD34 Uchida N; Li L; Nassehi T; Drysdale CM; Yapundich M; Gamer J; Haro-Mora JJ; Demirci S; Leonard A; Bonifacino AC; Krouse AE; Linde NS; Allen C; Peshwa MV; De Ravin SS; Donahue RE; Malech HL; Tisdale JF Cell Rep Med; 2021 Apr; 2(4):100247. PubMed ID: 33948577 [TBL] [Abstract][Full Text] [Related]
18. Rapid and Sensitive Assessment of Globin Chains for Gene and Cell Therapy of Hemoglobinopathies. Loucari CC; Patsali P; van Dijk TB; Stephanou C; Papasavva P; Zanti M; Kurita R; Nakamura Y; Christou S; Sitarou M; Philipsen S; Lederer CW; Kleanthous M Hum Gene Ther Methods; 2018 Feb; 29(1):60-74. PubMed ID: 29325430 [TBL] [Abstract][Full Text] [Related]
19. Editing the Sickle Cell Disease Mutation in Human Hematopoietic Stem Cells: Comparison of Endonucleases and Homologous Donor Templates. Romero Z; Lomova A; Said S; Miggelbrink A; Kuo CY; Campo-Fernandez B; Hoban MD; Masiuk KE; Clark DN; Long J; Sanchez JM; Velez M; Miyahira E; Zhang R; Brown D; Wang X; Kurmangaliyev YZ; Hollis RP; Kohn DB Mol Ther; 2019 Aug; 27(8):1389-1406. PubMed ID: 31178391 [TBL] [Abstract][Full Text] [Related]
20. Reactivation of γ-globin expression using a minicircle DNA system to treat β-thalassemia. Ma SP; Gao XX; Zhou GQ; Zhang HK; Yang JM; Wang WJ; Song XM; Chen HY; Lu DR Gene; 2022 Apr; 820():146289. PubMed ID: 35143940 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]